Moderna shares plunge on apparent cancer vaccine data leak

Chronological Source Flow

Back

AI Fusion Summary

Moderna shares have plunged following a reported leak of data concerning an experimental cancer vaccine. The company is collaborating with Merck on this project. Both Moderna and Merck are expected to officially share the Phase 3 data for the cancer vaccine this coming weekend during a medical conference. The stock tumble occurred as a direct result of the apparent data leak prior to the scheduled presentation of the clinical results at the event.